Novo Nordisk A/S - share repurchase programme

Summary by AI BETAClose X

Novo Nordisk announced a DKK 15 billion 12-month share buyback starting 4 February 2026; under the tranche initiated 6 May 2026 it may repurchase up to DKK 11,200,000,010.45 through 1 February 2027. As of 2 November 2026 the company has repurchased 41,714,179 B shares at an average price of DKK 277.23 for a total of DKK 11,564,364,801 and holds 55,754,876 B shares (1.2% of share capital) as treasury stock out of 4,465,000,000 total shares.

Disclaimer*

UK 100

Latest directors dealings